- Capital Cube•2 months agoInvivo Therapeutics Holdings Corp. :NVIV-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
Click here to see latest analysisInvivo Therapeutics Holdings Corp. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -6.62 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.NVIV-US‘s earnings and EBITDA […] (Read more...) The post Invivo Therapeutics Holdings Corp. :NVIV-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 appeared first on CapitalCube.
InVivo Therapeutics Holdings Corp.NasdaqGM
After hours: 6.610.00 (0.00%) as of 4:44 PM EDT
|Bid||6.35 x 500|
|52wk Range||3.50 - 15.37|
|Day's Range||6.53 - 6.69|
|Avg Vol (3m)||275,342|
As of 4:00 PM EDT. Market closed.